https://www.gosh.nhs.uk/news/gosh-chief-executive-to-leave-next-year/
GOSH Chief Executive to leave next year
13 Nov 2025, 11:30 a.m.
Great Ormond Street Hospital for Children has announced that its Chief Executive, Matthew Shaw, will be leaving in the new year to take up the role of Group Chief Executive of St George’s Epsom and St Helier University Hospitals and Health Group.
Mat has been at GOSH for the last seven years, firstly as Medical Director and then as Chief Executive since December 2018.
Speaking about his departure, he said: “GOSH is a special place. We look after children and young people with the some of the most complex health conditions in the UK.
“It’s been an absolute privilege to meet and care for some truly inspirational patients and families and to work with our wonderful partners – including the GOSH Charity – and supporters over the last seven and a half years. Most of all I have been very proud to lead such a dedicated workforce - their commitment to cutting edge research and providing the best possible clinical care to our patients is clear to see every single day.”
Ellen Schroder, Chair of Great Ormond Street Hospital, said: “Mat has led GOSH through a period of significant change, including the covid pandemic, and he leaves us with a new 5-year strategy and our brilliant Children’s Cancer Centre well on the way to being built.
“Mat has been an incredible asset to our hospital and has contributed to NHS way beyond the walls of GOSH. He will be much missed, and I would like to wish him all the very best in his new role.”
An announcement about Mat’s replacement will be made in due course.
GOSH celebrates Rare Disease Day 2026 with local community
GOSH specialises in rare disease research and to celebrate, we recently invited two local North London Year 4 classes to join us for the day to learn about how we care for patients with rare diseases.
Professor Francesco Muntoni wins prestigious research prize
Professor Francesco Muntoni, GOSH Paediatric Neurology Consultant, has been awarded the 2026 Novo Nordisk Prize in recognition of his pioneering work transforming the outlook for children with Duchenne muscular dystrophy (DMD).
GOSH secures £1.4m in NIHR capital equipment funding to boost research capability
This investment will significantly strengthen our research infrastructure and enhance our ability to deliver world‑leading paediatric research across the whole hospital.
Karl Munslow Ong appointed as Chief Executive of Great Ormond Street Hospital
Great Ormond Street Hospital for Children (GOSH) is delighted to announce the appointment of Karl Munslow Ong as its new Chief Executive.